1. Home
  2. CSTE vs SNTI Comparison

CSTE vs SNTI Comparison

Compare CSTE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

N/A

Current Price

$0.75

Market Cap

27.7M

Sector

Industrials

ML Signal

N/A

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

N/A

Current Price

$1.00

Market Cap

22.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTE
SNTI
Founded
1987
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
22.8M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CSTE
SNTI
Price
$0.75
$1.00
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$9.00
AVG Volume (30 Days)
296.9K
116.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.80
52 Week High
$3.35
$5.10

Technical Indicators

Market Signals
Indicator
CSTE
SNTI
Relative Strength Index (RSI) 19.88 53.76
Support Level N/A $0.80
Resistance Level $2.00 $1.02
Average True Range (ATR) 0.20 0.06
MACD -0.09 0.02
Stochastic Oscillator 3.74 86.08

Price Performance

Historical Comparison
CSTE
SNTI

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: